Adams Diversified Equity Fund’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-113,400
Closed -$11.8M 232
2017
Q4
$11.8M Buy
+113,400
New +$12.8M 0.64% 60
2016
Q2
Sell
-164,000
Closed -$16.4M 201
2016
Q1
$16.4M Hold
164,000
1.14% 41
2015
Q4
$19.6M Hold
164,000
1.35% 30
2015
Q3
$17.7M Hold
164,000
1.28% 31
2015
Q2
$19M Hold
164,000
1.25% 34
2015
Q1
$18.9M Hold
164,000
1.24% 32
2014
Q4
$18.3M Hold
164,000
1.21% 29
2014
Q3
$15.5M Hold
164,000
1.02% 41
2014
Q2
$14.1M Sell
164,000
-76,000
-32% -$5.78M 0.94% 46
2014
Q1
$16.8M Hold
240,000
1.18% 32
2013
Q4
$20.3M Hold
240,000
1.43% 21
2013
Q3
$18.5M Hold
240,000
1.41% 27
2013
Q2
$14M Buy
+240,000
New +$14.4M 1.11% 39

Other funds holding CELG

Adams Diversified Equity Fund's CELG Position: Q1 2018 in Review

Adams Diversified Equity Fund sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 113,400 shares — an estimated $11.8M sold.

Adams Diversified Equity Fund first reported a position in CELG in Q2 2013 and held it in 13 quarters. The position peaked at $20.3M in Q4 2013. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Adams Diversified Equity Fund reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Adams Diversified Equity Fund sold 113,400 Celgene Corp shares in Q1 2018, an estimated $11.8M.
  • Adams Diversified Equity Fund first reported a position in Celgene Corp in Q2 2013 and held it in 13 quarters.
  • Adams Diversified Equity Fund's Celgene Corp position peaked at $20.3M in Q4 2013.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Adams Diversified Equity Fund's 13F filing for Q1 2018, filed 27 Apr 2018.